WASHINGTON (Reuters) - Health Officials are weighing stricter labels on the widely used new generation of Birth Control pills, based on data showing they may put women at a higher risk of dangerous blood clots. U.S. Food And Drug Administration staff reviewed studies comparing an older generation of birth control with newer pills that contain the compound drospirenone, such as Bayer AG's popular Yaz and Yasmin. ... read more..
Sunday, 11 March 2012
Food And Drug Administration-Dangerous Blood Clots-Birth Control Pills-Health Officials
Friday, 9 March 2012
Food And Drug Administration-Dangerous Blood Clots-Birth Control Pills-Generation
ADELPHI, Maryland (Reuters) - Health advisers recommended a revision of labels for the widely used new generation of Birth Control pills, based on data showing they may put women at a higher risk of dangerous blood clots. Outside experts advising the Food And Drug Administration on Thursday voted 21-5 that current labels inadequate reflected the risks and benefits of a newer generation of pills that contain the compound drospirenone, including Bayer AG's popular Yaz and Yasmin. ... read more..
Saturday, 25 February 2012
Dangerous Blood Clots-Birth Control Pills-Generation
| |
| A chemist displays birth control pill of German drugmaker Schering and a cortisone of drugs and chemicals group Merck in a Berlin apothecary |
ADELPHI, Maryland (Reuters) - U.S. health advisers recommended a revision of labels for the widely used new generation of birth control pills, based on data showing they may put women at a higher risk of dangerous blood clots. Although all common birth control pills increase women's chances of getting blood clots, concerns have recently been mounting about an even higher risk linked to a newer generation of pills that contain the compound drospirenone, such as Bayer AG's popular Yaz and Yasmin. ... read more..